Lorena has over 20 years of experience in clinical development, with more than seven years specializing in study start up. Currently, Amber is leading the IT implementation of the regulatory information management (RIM) program to transform the regulatory submission process to improve overall quality and speed. Amber is the chair of Women in IDS at Lilly, an organization designed to foster an environment where women in IT thrive. She built strategies and solutions around clinical lab results modernization, clinical users working environment, and the initial strategy work for devices and digital biomarkers in clinical trials. She then led the initial analytics solution implementation for risk-based monitoring at Lilly. In her early career, Amber led several large-scale research IT initiatives focusing on analytical chemistry and in vitro biology. Amber holds a bachelor of science degree from Indiana University – Kelley School of Business in computer information systems with a minor in biology. She holds a BS degree in biology and chemistry from Averett College and a master’s in healthcare management from Saint Joseph’s University.Īmber is an information technology professional at Eli Lilly and Company with over 20 years of experience across research, clinical, and regulatory affairs. In 2013, she assumed the additional responsibility for commercial quality and compliance oversight of finished dosage forms as well as devices manufactured for and on behalf of Gilead. In 2010, Valerie joined Gilead to lead the Commercial API Quality group responsible for the external supply of active pharmaceutical ingredients formulated in drug products. She has over twenty-five years of experience in the pharmaceutical and biopharmaceutical industries with expertise in quality control, quality assurance, and worldwide health authority regulations. She leads a global team, including internal sites and PDM affiliates, responsible for quality and compliance in producing and distributing active pharmaceutical ingredients, drug product intermediates, oral solid dosage forms, parenterals, biologics, and medical devices for worldwide development and commercial markets. Valerie is senior vice president of quality assurance in pharmaceutical development and manufacturing at Gilead Sciences, Inc. He holds a bachelor of science degree in computer science from Oregon State University. He was a key visionary force behind three of the industry’s most successful enterprise application platforms: Veeva Vault, the Salesforce Platform, and PeopleTools.Peter currently serves on the board of directors of Veeva and Zoom. Today, Veeva helps more than 1,000 life sciences companies bring new medicines and treatments to patients faster.With more than 30 years experience at leading technology companies, Peter has been at the forefront of every major transition in enterprise software, from the mainframe at IBM Silicon Valley Lab, to client-server at PeopleSoft, the cloud at Salesforce, and industry cloud software at Veeva. He pioneered the industry cloud category when he founded Veeva in 2007 with the belief that vertical cloud software would be the next wave of cloud innovation. Peter Gassner is the visionary behind Veeva, one of the world’s most successful and innovative cloud software companies.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |